Track topics on Twitter Track topics that are important to you
Actelion’s successor Idorsia reported its candidate for insomnia met the primary endpoint in Phase II and will advance to Phase III. In its first report from the clinic last Friday, Idorsia announced positive results from a Phase II trial for ...
This awesome article Actelion’s Reincarnation Comes Out Swinging with Phase II Success in Insomnia appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)NEXT ARTICLE
Sleep disorders disrupt sleep during the night, or cause sleepiness during the day, caused by physiological or psychological factors. The common ones include snoring and sleep apnea, insomnia, parasomnias, sleep paralysis, restless legs syndrome, circa...
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...